Increased sensitivity to strong perturbations in a whole-brain model of LSD
This in silico modelling study, based on fMRI data from healthy volunteers (n=14) administered LSD (75 μg), investigated brain-wide dynamical stability. It finds that LSD shifts the brain towards a more unstable, complex state, with the most significant dynamical changes occurring in the limbic, visual, and default mode networks.
Authors
- Robin Carhart-Harris
- Leor Roseman
- Mendel Kaelen
Published
Abstract
Lysergic acid diethylamide (LSD) is a potent psychedelic drug, which has seen a revival in clinical and pharmacological research within recent years. Human neuroimaging studies have shown fundamental changes in brain-wide functional connectivity and an expansion of dynamical brain states, thus raising the question about a mechanistic explanation of the dynamics underlying these alterations. Here, we applied a novel perturbational approach based on a whole-brain computational model, which opens up the possibility to externally perturb different brain regions in silico and investigate differences in dynamical stability of different brain states, i.e. the dynamical response of a certain brain region to an external perturbation. After adjusting the whole-brain model parameters to reflect the dynamics of functional magnetic resonance imaging (fMRI) BOLD signals recorded under the influence of LSD or placebo, perturbations of different brain areas were simulated by either promoting or disrupting synchronization in the regarding brain region. After perturbation offset, we quantified the recovery characteristics of the brain area to its basal dynamical state with the Perturbational Integration Latency Index (PILI) and used this measure to distinguish between the two brain states. We found significant changes in dynamical complexity with consistently higher PILI values after LSD intake on a global level, which indicates a shift of the brain's global working point further away from a stable equilibrium as compared to normal conditions. On a local level, we found that the largest differences were measured within the limbic network, the visual network and the default mode network. Additionally, we found a higher variability of PILI values across different brain regions after LSD intake, indicating higher response diversity under LSD after an external perturbation. Our results provide important new insights into the brain-wide dynamical changes underlying the psychedelic state - here provoked by LSD intake - and underline possible future clinical applications of psychedelic drugs in particular psychiatric disorders.
Research Summary of 'Increased sensitivity to strong perturbations in a whole-brain model of LSD'
Introduction
Recent neuroimaging studies indicate that LSD produces widespread changes in brain functional connectivity and an expanded repertoire of dynamical brain states, including increased BOLD variance and greater diversity of dynamic functional connectivity patterns. Despite these empirical observations, a mechanistic understanding of how whole-brain dynamics are altered by LSD is incomplete. Previous work using controlled perturbations (for example TMS or DBS) has shown the value of probing dynamical responses, but in vivo perturbations are limited in scope, duration and regional specificity. Jobst and colleagues set out to combine a whole-brain computational model with an in silico perturbational approach to explore how the brain’s dynamical stability differs under LSD versus placebo across three scanning conditions: rest, rest while listening to music, and rest after music. Using a Hopf-based whole-brain model fitted to fMRI data recorded under LSD and placebo, the investigators simulated region-specific perturbations and quantified recovery dynamics with the Perturbational Integration Latency Index (PILI). They hypothesised that LSD would produce stronger and longer-lasting responses to perturbation—consistent with dynamics closer to bifurcation or criticality—and expected music to amplify these effects.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Jobst, B. M., Atasoy, S., Ponce-Alvarez, A., Sanjuán, A., Roseman, L., Kaelen, M., Carhart-Harris, R., Kringelbach, M. L., & Deco, G. (2021). Increased sensitivity to strong perturbations in a whole-brain model of LSD. NeuroImage, 230, 117809. https://doi.org/10.1016/j.neuroimage.2021.117809
References (27)
Papers cited by this study that are also in Blossom
Atasoy, S., Leor, R., Kaelen, M. et al. · Scientific Reports (2017)
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Carhart-Harris, R. L., Leech, R., Erritzoe, D. et al. · Schizophrenia Bulletin (2012)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Fuentes, J. J., Fonseca, F., Elices, M. et al. · Frontiers in Psychiatry (2020)
Show all 27 referencesShow fewer
Girn, M., Roseman, L., Bernhardt, B. et al. · Biorxiv (2020)
Kaelen, M., Barrett, F. S., Roseman, L. et al. · Psychopharmacology (2015)
Kaelen, M., Roseman, L., Kahan, J. et al. · European Neuropsychopharmacology (2016)
Lenz, C., Dolder, P. C., Lang, U. E. et al. · Acta Psychiatrica Scandinavica (2017)
Müller, F., Dolder, P. C., Schmidt, A. et al. · NeuroImage (2018)
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J. et al. · Journal of Neuroscience (2013)
Nichols, D. E. · Pharmacological Reviews (2016)
Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)
Passie, T., Halpern, J. H., Stichtenoth, D. O. et al. · CNS Neuroscience and Therapeutics (2008)
Preller, K. H., Herdener, M., Pokorny, T. et al. · Current Biology (2017)
Preller, K. H., Razi, A., Zeidman, P. et al. · PNAS (2019)
Roseman, L., Haijen, E. C. H. M., Idialu-Ikato, K. et al. · Journal of Psychopharmacology (2019)
Roseman, L., Demetriou, L., Wall, M. B. et al. · Neuropharmacology (2018)
Roseman, L., Leech, R., Feilding, A. et al. · Frontiers in Human Neuroscience (2014)
Schartner, M., Carhart-Harris, R. L., Barrett, A. B. et al. · Scientific Reports (2017)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Varley, T. F., Carhart-Harris, R., Roseman, L. et al. · NeuroImage (2020)
Cited By (11)
Papers in Blossom that reference this study
Piccinini, J. I., Perl, Y. S., Pallavicini, C. et al. · Communications Biology (2025)
Shinozuka, K., Tewarie, P. K. B., Luppi, A. et al. · Biorxiv (2024)
Girn, M., Rosas, F. E., Daws, R. E. et al. · Trends in Cognitive Sciences (2023)
Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E. et al. · Neuropharmacology (2023)
Gattuso, J. J., Perkins, D., Ruffell, S. G. D. et al. · International Journal of Neuropsychopharmacology (2022)
Cruzat, J., Perl, Y. S., Escrichs, A. et al. · Network Neuroscience (2022)
Hipólito, I., Mago, J., Rosas, F. E. et al. · Psyarxiv (2022)
McCulloch, D. E-W., Knudsen, G. M., Barrett, F. S. et al. · Neuroscience and Biobehavioral Reviews (2022)
Lawn, T., Dipasquale, O., Vamvakas, A. et al. · Psychopharmacology (2022)
Zamani, A., Carhart-Harris, R. L., Christoff, K. · Neuropsychopharmacology (2021)
Show all 11 papersShow fewer
Girn, M., Roseman, L., Bernhardt, B. et al. · Biorxiv (2020)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.